Jarab AS, Alqudah SG, Mukattash TL, et al. Randomized controlled trial of clinical pharmacy management of patients with type 2 diabetes in an outpatient diabetes clinic in Jordan

AIZaytoonah University of Jordan, Pharmacy, P.O. Box 130, Amman, Jordan 11733. .
Journal of managed care pharmacy: JMCP (Impact Factor: 2.71). 09/2012; 18(7):516-26. DOI: 10.1136/ejhpharm-2013-000276.576
Source: PubMed


Glycemic goals (hemoglobin A1c less than  7%) are often not achieved in patients with type 2 diabetes despite the availability of many effective treatments and the documented benefits of glycemic control in the reduction of long-term microvascular and macrovascular complications. Several studies have established the important positive effects of pharmacist-led management on achieving glycemic control and other clinical outcomes in patients with diabetes. Diabetes prevalence and mortality are increasing rapidly in Jordan. Nevertheless, clinical pharmacists in Jordan do not typically provide pharmaceutical care; instead, the principal responsibilities of pharmacists in Jordan are dispensing and marketing of medical products to physicians.
To assess the primary clinical outcome of glycemic control (A1c) and secondary outcomes, including blood pressure, lipid values, self-reported medication adherence, and self-care activities for patients with type 2 diabetes in an outpatient diabetes clinic randomly assigned to either usual care or a pharmacist-led pharmaceutical care intervention program.
Patients with type 2 diabetes attending an outpatient diabetes clinic of a large teaching hospital were recruited over a 4-month period from January through April 2011 and randomly assigned to intervention and usual care groups using the Minim software technique. The intervention group at baseline received face-to-face objective-directed education from a clinical pharmacist about type 2 diabetes, prescription medications, and necessary lifestyle changes, followed by 8 weekly telephone follow-up calls to discuss and review the prescribed treatment plan and to resolve any patient concerns. The primary outcome measure was glycemic control (A1c), and secondary measures included systolic and diastolic blood pressure, complete lipid profile (i.e., total cholesterol, low-density lipoprotein cholesterol [LDL-C], high-density lipoprotein cholesterol [HDL-C], serum triglycerides), and self-reported medication adherence (4-item Morisky Scale) and self-care activities (Summary of Diabetes Self-Care Activities questionnaire). Data were collected at baseline and at 6 months follow-up. Changes from baseline to follow-up were calculated for biomarker values, and between-group differences in the change amounts were tested using the t test for independent samples. A P value of less than  0.05 was considered 
statistically significant.
A total of 77 of 85 patients (90.6%) randomly assigned to the intervention group and 79 of 86 patients (91.9%) assigned to usual care had baseline and 6-month follow-up values. Compared with baseline values, patients in the intervention group had a mean reduction of 0.8% in A1c versus a mean increase of 0.1% from baseline in the usual care group (P = 0.019). The intervention group compared with the usual care group had small but statistically significant improvements in the secondary measures of fasting blood glucose, systolic and diastolic blood pressure, total cholesterol, LDL-C, serum triglycerides, self-reported medication adherence, and self-care activities. Between-group differences in changes in the secondary measures of HDL-C and body mass index were not significant.
Patients with type 2 diabetes who received pharmacist-led pharmaceutical care in an outpatient diabetes clinic experienced reduction in A1c at 6 months compared with essentially no change in the usual care group. Six of 8 secondary biomarkers were improved in the intervention group compared with usual care.

Download full-text


Available from: Tareq Mukattash, Mar 17, 2014
  • Source
    • "Need for intervention by clinical pharmacist (CP) and infectious disease (ID) consultants in managing the policy is well established. Clinical pharmacist interventions eliminate (37.4%) of treatment problems related to efficacy and monitoring of medications (Aburuz et al., 2013), promote efficacy of therapy (Jarab et al., 2012), and enhance desired health outcomes (Jarab et al., 2011). Frequent and prolonged use of broad-spectrum antimicrobial agents promote emergence of resistance (Velickovic-Radovanovic et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: What is known and Objective There is little research on the impact of implementing and monitoring antimicrobial policy in Saudi hospitals. The purpose of this study is to measure the impact of the clinical pharmacist (CP) and infectious disease consultant (ID) interventions on the use of three antimicrobials (Caspofungin, imipenem, meropenem) in hospitalized patients in King Abdullah Medical City hospital. Methods The study was carried out in King Abdullah Medical City, in Mekkah, Saudi Arabia. The hospital is a tertiary center that provide CCU, CSICU, Cardiac, Hematology, ICU, Medical, Neuroscience, Oncology, and specialized surgery services. The use of three antimicrobials (Caspofungin, Imipenem, Meropenem) was reviewed by the clinical Pharmacist for four periods, pre and post implementation of policy. Relevant data were collected in four periods. In the first period, before policy implementing, the data were collected retrospectively to be used as baseline status reference, and in the three remaining periods that followed data were collected prospectively, and compared to base line data, to evaluate role of clinical pharmacist and ID interventions in optimizing antimicrobial therapy. Results and discussion Caspofungin duration of therapy was not affected significantly by the intervention. Statistically significant reduction in antimicrobial therapy duration was observed in imipenem (37%) and meropenem (37%) from baseline, which indicate better control on antimicrobial use and reduction in antimicrobial resistance. What is new and Conclusion The impact of the clinical pharmacist and ID interventions, in reducing antimicrobial therapy duration using imipenem and meropenem, is clear from the result presented above. However, lack of restriction and follow up in the antimicrobial policy in case of negative culture makes antimicrobial use uncontrollable in these cases. Establishing good and accepted policy may help reduce consumption and total cost of therapy.
    Full-text · Article · Feb 2014 · Saudi Pharmaceutical Journal
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In recent decades, by increasing complexity of drug therapy, pharmacists considered as health-care members who can help optimizing drug therapy. We know that medicines do not have the anticipated effects all the times and a vast variability may exist in their behaviors in the body. So, it is very crucial to individualize treatment for every single patient. Nowadays, optimizing drug therapy in patients needs a collaborative interdisciplinary approach to patients care and treatment. Specifically when drug therapy is considered for a condition, pharmacists can enroll as a valuable professional to help for modification of therapy along with other clinicians. Abundant number of studies and reports exist in the literatures which address usefulness of pharmacist engagement in patient care. In this review we have presented some valuable evidences supporting pharmacist role in different clinical settings.
    Full-text · Article · Jan 2013
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objectives The aim of this review was to explore the literature relating to the role of pharmacists as culturally directed diabetes educators in the Arabic-speaking community in Australia. Methods A systematic search was made of international peer-reviewed literature in PubMed, Medline, Cochrane Library and the grey literature according to the PRISMA systematic review guidelines. Key findings The search yielded 13 studies that met the inclusion criteria. Evidence of the effectiveness of pharmacists’ role in the management and education of patients with type 2 diabetes mellitus was abundant in the literature. Many studies examined pharmacists’ management and education of diabetic patients in general, but not of Arabic-speaking patients specifically. Conclusion Future research examining the role of pharmacists as diabetes educators and the needs of Arabic-speaking diabetic patients is of importance to optimize health outcomes and minimize costs related to treatment and complications. Keywords Arabic; education; pharmacist; type 2 diabetes
    Full-text · Article · Jun 2013 · Journal of Pharmaceutical Health Services Research
Show more